Home
|Insights
|Re. summary proceedings and biosimilar pharmaceuticals: "Biosimilars en Belgische octrooigeschillen (zoals) in kort geding: een geïnformeerd magistraat is meer waard," IRDI

PDF Link

Re. summary proceedings and biosimilar pharmaceuticals: "Biosimilars en Belgische octrooigeschillen (zoals) in kort geding: een geïnformeerd magistraat is meer waard," IRDI

Publication | 09.01.13

Attachments

Download Attachment
Biosimilars And Belgian Patent Disputes

Contacts

Jan-Diederik Lindemans
Partner
- Brussels
  - D | +32.2.282.1832
amxpbmRlbWFuc0Bjcm93ZWxsLmNvbQ==

Insights

Publication | 03.01.26

Anything Humans Can Do, GenAI Can Do . . . Worse?

Publication | 02.19.26
The QICDRC Practice Direction on the Use of Artificial Intelligence
Publication | 02.12.26
Westlaw Today: Optimum's Shot Across the Bow: An Antitrust Challenge to Cooperation Agreements
Publication | 02.06.26
Protecting Sensitive Data During Congressional Inquiries

View All Insights

Subscribe

to the latest insights from our team